At Invitris we want...
…to create new Product and manufacture them in partner with other companies
Why us?
Our universal platform technology enables generating synthetic proteins at the highest yields and purity and allows manufacturing at scale
We specialize in:
phages, tailocins, endolysins, neoantigens, vaccines, antibodies, and toxic proteins (e.g., nucleases and proteases)
Our Industries
Previous slide
Next slide
Supported by
